← Back to Search

Specialized Employment Program for Autism

N/A
Recruiting
Led By Lawrence Fung, MD, PhD
Research Sponsored by Lawrence Fung
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Between the ages of 18-55
Able to travel to work independently
Timeline
Screening 3 weeks
Treatment Varies
Follow Up at screening, 3 months after onboarding at job position, 6 months after onboarding, 12 months after onboarding, 15 months after onboarding, 18 months after onboarding.
Awards & highlights

Study Summary

This trial will examine whether the Neurodiversity at Work Program at Stanford University improves employment outcomes for adults with autism spectrum disorder.

Who is the study for?
This trial is for adults aged 18-55 with Autism Spectrum Disorder (ASD) who can travel to work on their own. They should have completed an internship, pre-employment training, or both and must have a college degree. Participants need to have an IQ within the range of 60 and above, without significant current psychosocial stressors.Check my eligibility
What is being tested?
The study tests the effectiveness of Stanford University's Neurodiversity at Work (NaW) Program compared to traditional vocational support. It aims to see if NaW helps adults with ASD maintain steady jobs and improve their quality of life.See study design
What are the potential side effects?
Since this trial involves employment support programs rather than medical interventions, there are no direct side effects like those associated with medications or clinical treatments.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am between 18 and 55 years old.
Select...
I can travel to work on my own.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~at screening, 3 months after onboarding at job position, 6 months after onboarding, 12 months after onboarding, 15 months after onboarding, 18 months after onboarding.
This trial's timeline: 3 weeks for screening, Varies for treatment, and at screening, 3 months after onboarding at job position, 6 months after onboarding, 12 months after onboarding, 15 months after onboarding, 18 months after onboarding. for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Costs of Employee Turnover
Duration of Sustained Employment
Job Retention Rates
+2 more
Secondary outcome measures
ANZ Financial Well-being Scale
Eisenberger's Perceived Organizational Support
Judge's Global Job Satisfaction
+5 more
Other outcome measures
Autism Spectrum Quotient
Patient Health Questionnaire (PHQ-9)
Rosenberg Scale of Self-Esteem
+2 more

Trial Design

2Treatment groups
Experimental Treatment
Group I: Neurodiversity at Work - Delayed Start (NaW-DS)Experimental Treatment1 Intervention
Participants in this group will receive typical orientation for neurotypical employees after onboarding. The support of peer mentor, job/life skills coach, vocational rehabilitation counselor, and a personal counselor will start 6 months after onboarding. Managers, co-workers, team buddies and mentors for all recruited and hired employees in both groups will receive the same specialized training to enhance their abilities to work with individuals with ASD.
Group II: Neurodiversity at Work (NaW) GroupExperimental Treatment1 Intervention
Individuals in this group will receive a 6-week Autism at Work pre-employment training. Upon onboarding, each individual will be supported by a team manager, a team buddy, a peer mentor, a job/life skills coach, a vocational rehabilitation counselor, and a personal counselor. Ongoing support for members of support circles will be provided during the 12 weeks immediately after onboarding.

Find a Location

Who is running the clinical trial?

Rangam ConsultantsUNKNOWN
3R Behavioral SolutionsUNKNOWN
Lawrence FungLead Sponsor

Media Library

NaW Clinical Trial Eligibility Overview. Trial Name: NCT04107064 — N/A
Autism Research Study Groups: Neurodiversity at Work (NaW) Group, Neurodiversity at Work - Delayed Start (NaW-DS)
Autism Clinical Trial 2023: NaW Highlights & Side Effects. Trial Name: NCT04107064 — N/A
NaW 2023 Treatment Timeline for Medical Study. Trial Name: NCT04107064 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the participant cap for this research endeavor?

"Affirmative, the clinicaltrials.gov portal confirms that this medical trial is presently recruiting individuals. This study was first posted on September 30th 2019 and its most recent revision occurred on September 17th 2021. Eighty participants need to be sourced from a single site for this research endeavour."

Answered by AI

Is the trial open to individuals who are under 25 years of age?

"This medical study is enrolling individuals who are above the age of consent and below 55 years old."

Answered by AI

What criteria must individuals fulfill to be eligible for this medical experiment?

"This clinical investigation is open to 80 individuals, aged 18-55, who have been diagnosed with early infantile autism. Additional criteria for enrolment include: gender neutrality, a lack of psychosocial stressors per history, independent travel capacity, participation in an internship program or pre-employment training (or both), IQ scores between 60 and 90 (for those without college degrees) or higher than 90 (with possession of a degree)."

Answered by AI

What goals is this experimental endeavor attempting to attain?

"The primary outcome to be measured 15 months after onboarding is the Rate of Job Offers. Secondary outcomes include Work Motivation and Engagement (UWES) quantified with a 0-102 point scale, ANZ Financial Well-being Scale ranging from 0-11 points, and MOAQ Subscale: Intent to Turnover scored between 3 and 21 which indicates an individual's likelihood of job turnover."

Answered by AI

Is recruitment still taking place for this clinical trial?

"Correct. According to data on clinicaltrials.gov, this study is actively seeking patients; it was initially posted on September 30th 2019 and most recently edited on the 17th of September 2021. 80 individuals are sought from one site for enrollment in the trial."

Answered by AI

Who else is applying?

What state do they live in?
New York
Pennsylvania
How old are they?
18 - 65
What portion of applicants met pre-screening criteria?
Did not meet criteria
~21 spots leftby Dec 2025